Key result
HRV cluster analysis reveals significant cardiac autonomic dysfunction in ~52% of unmedicated acute schizophrenia patients.
Why the study?
Underlying biological mechanisms driving increased cardiac mortality in schizophrenia are largely unknown, though cardiac autonomic dysfunction represents an important physiological link to cardiovascular disease.
Does heart rate variability analysis identify cardiac autonomic dysfunction in unmedicated patients with acute schizophrenia compared to healthy controls?
Cross-Sectional (n=238)
No
Does heart rate variability analysis identify cardiac autonomic dysfunction in unmedicated patients with acute schizophrenia compared to healthy controls?
Approximately half of unmedicated patients with acute schizophrenia exhibit significant cardiac autonomic dysfunction as measured by HRV, highlighting a potential mechanism for their increased cardiovascular risk.
May indicate elevated CV risk in acute schizophrenia; leaves open prognostic value and HRV screening utility.
Underlying biological mechanisms leading to the dramatically increased cardiac mortality in patients with schizophrenia (SCZ) are largely unknown. Cardiac autonomic dysfunction (CADF), which has been extensively described in patients with SCZ, represents an important physiological link to cardiovascular disease (CVD). This study investigated the prevalence of CADF in patients with SCZ using HRV across multiple domains (time and frequency, nonlinear dynamics, complexity measures, symbolic dynamics, and segmented Poincaré plot analysis). HRV-based clustering classified 119 SCZ patients as having or not having CADF based on deviations from 119 age- and sex-matched healthy controls. Our findings showed that approximately half of the patients had normal cardiac autonomic function, while the other half had significant abnormalities. The severity of CADF correlated with age, body mass indes (BMI), disease duration, and symptom severity. About half of SCZ patients have significant CADF, which increases their risk for cardiac events. These findings highlight the potential of HRV-based biomarkers in improving CVD risk prediction and stratification in SCZ. Future research should explore integrating HRV analysis with other biomarkers to enhance early detection and intervention strategies.
No takes yet. Share an insight, caveat, or question.
Refisch et al. (2025) conducted a cross-sectional in Acute Schizophrenia (n=238). Schizophrenia (unmedicated) vs. Healthy controls was evaluated on Prevalence of cardiac autonomic dysfunction (CADF) based on HRV clustering. Cluster analysis of heart rate variability parameters revealed that 52.1% of unmedicated patients with acute schizophrenia had significant cardiac autonomic dysfunction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: